Market Overview:
The global ear drops market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of ear infections, rising awareness about ear care, and growing demand for over-the-counter (OTC) drugs. In addition, the increasing use of combination therapies is also contributing to the growth of this market. On the basis of type, ciprodex ear drop segment is expected to account for a major share in terms of revenue in 2018 and is projected to maintain its dominance during the forecast period as well. This can be attributed to its high efficacy against various types of bacteria and viruses that cause ear infections. Gentisone HC Ear Drop segment is projected grow at highest CAGR during forecast period owing high adoption by pediatric population suffering from recurrent otitis media (OM). Based on application, adults segment accounted for majority share in 2017 and it will continue its dominance throughout forecast period due higher incidence rate os adult OM as compared children OM across globe .
Product Definition:
Ear Drops are a liquid medication which is placed into the ear in order to treat various conditions. Ear Drops can be used to help relieve pain, remove ear wax, or fight infection.
Ciprodex Ear Drop:
Ciprodex is a prescription medicine used for the treatment of wax build up or blockage in the ear. It is also used to treat infections and inflammations in the ear. The active ingredient in Ciprodex Ear Drop, Hydrogen Peroxide, has antiseptic properties which help fight against bacterial infection. This makes it an effective treatment for various types of ear diseases as well as helps prevent them from coming back again after proper treatment.
Gentisone HC Ear Drop:
Gentisone HC is a topical anti-inflammatory drug that reduces inflammation by inhibiting the action of cytokines. Gentisone HC ear drop works by decreasing pain and itching in the infected ear, while also reducing any swelling or inflammation of the outer ear. It is commonly used for acute otitis media (AOM), which is an infection in the middle or inner part of an ear canal.
Application Insights:
Adults segment held the largest share of over 70.0% in 2017. The large share can be attributed to the high incidence rate of ENT disorders among adults as compared to children. For instance, according to a study published in Journal Of Laryngology & Otolaryngology, around 75% of laryngotracheal surgery is performed on adult patients as compared to 25% on pediatric patients. Growing geriatric population across the globe is also expected to contribute towards significant growth during forecast period.
The growing prevalence and awareness about ear drops are anticipated drive demand for Ciprodex Ear Drop from 2018 to 2030 owingto its ease of use and rapid relief from symptoms such as itching, pain.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the local presence of major players, high disposable income, and availability of advanced healthcare infrastructure. In addition, increasing incidence of otitis media is anticipated to drive growth over the forecast period. According to a study published in NCBI (National Center for Biotechnology Information), an estimated 14 million people suffer from acute Otitis Media (OM) annually in U.S., with peak prevalence occurring during winter season between December and February every year.
Growth Factors:
- Increasing prevalence of ear infections: The increasing prevalence of ear infections is one of the key growth drivers for the Ear Drops market. According to a study by the Centers for Disease Control and Prevention (CDC), around 23 million cases of acute otitis media are reported in the U.S. each year, resulting in nearly 7 million doctor visits and over 2 million prescriptions for antibiotics annually. This is expected to drive demand for Ear Drops products significantly in the coming years.
- Rising awareness about ear care: There is a growing awareness among people about proper ear care, which is driving demand for Ear Drops products worldwide. In addition, manufacturers are focusing on marketing their products through various channels such as television commercials, online campaigns, etc., to create more awareness about their benefits among consumers globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Ear Drops Market Research Report
By Type
Ciprodex Ear Drop, Gentisone HC Ear Drop, Ciproxin HC Ear Drop
By Application
Adults, Children
By Companies
Daiichi Sankyo, Neilmed, TRP, Prestige Brands, Inc, Walgreen, Hyland's, Similasan, Clarion Brands Inc, Debrox, Auro-Dri Ear, Equate
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Ear Drops Market Report Segments:
The global Ear Drops market is segmented on the basis of:
Types
Ciprodex Ear Drop, Gentisone HC Ear Drop, Ciproxin HC Ear Drop
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Adults, Children
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Daiichi Sankyo
- Neilmed
- TRP
- Prestige Brands, Inc
- Walgreen
- Hyland's
- Similasan
- Clarion Brands Inc
- Debrox
- Auro-Dri Ear
- Equate
Highlights of The Ear Drops Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ciprodex Ear Drop
- Gentisone HC Ear Drop
- Ciproxin HC Ear Drop
- By Application:
- Adults
- Children
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ear Drops Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Ear drops are a type of medication that is used to treat ear infections. Ear drops contain an antibiotic or other medicine and are inserted into the ear canal to help fight the infection.
Some of the major companies in the ear drops market are Daiichi Sankyo, Neilmed, TRP, Prestige Brands, Inc, Walgreen, Hyland's, Similasan, Clarion Brands Inc, Debrox, Auro-Dri Ear, Equate.
The ear drops market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Ear Drops Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Ear Drops Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Ear Drops Market - Supply Chain
4.5. Global Ear Drops Market Forecast
4.5.1. Ear Drops Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Ear Drops Market Size (000 Units) and Y-o-Y Growth
4.5.3. Ear Drops Market Absolute $ Opportunity
5. Global Ear Drops Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Ear Drops Market Size and Volume Forecast by Type
5.3.1. Ciprodex Ear Drop
5.3.2. Gentisone HC Ear Drop
5.3.3. Ciproxin HC Ear Drop
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Ear Drops Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Ear Drops Market Size and Volume Forecast by Application
6.3.1. Adults
6.3.2. Children
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Ear Drops Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Ear Drops Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Ear Drops Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Ear Drops Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Ear Drops Demand Share Forecast, 2019-2026
9. North America Ear Drops Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Ear Drops Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Ear Drops Market Size and Volume Forecast by Application
9.4.1. Adults
9.4.2. Children
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Ear Drops Market Size and Volume Forecast by Type
9.7.1. Ciprodex Ear Drop
9.7.2. Gentisone HC Ear Drop
9.7.3. Ciproxin HC Ear Drop
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Ear Drops Demand Share Forecast, 2019-2026
10. Latin America Ear Drops Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Ear Drops Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Ear Drops Market Size and Volume Forecast by Application
10.4.1. Adults
10.4.2. Children
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Ear Drops Market Size and Volume Forecast by Type
10.7.1. Ciprodex Ear Drop
10.7.2. Gentisone HC Ear Drop
10.7.3. Ciproxin HC Ear Drop
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Ear Drops Demand Share Forecast, 2019-2026
11. Europe Ear Drops Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Ear Drops Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Ear Drops Market Size and Volume Forecast by Application
11.4.1. Adults
11.4.2. Children
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Ear Drops Market Size and Volume Forecast by Type
11.7.1. Ciprodex Ear Drop
11.7.2. Gentisone HC Ear Drop
11.7.3. Ciproxin HC Ear Drop
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Counry
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Ear Drops Demand Share, 2019-2026
12. Asia Pacific Ear Drops Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Ear Drops Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Ear Drops Market Size and Volume Forecast by Application
12.4.1. Adults
12.4.2. Children
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Ear Drops Market Size and Volume Forecast by Type
12.7.1. Ciprodex Ear Drop
12.7.2. Gentisone HC Ear Drop
12.7.3. Ciproxin HC Ear Drop
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Ear Drops Demand Share, 2019-2026
13. Middle East & Africa Ear Drops Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Ear Drops Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Ear Drops Market Size and Volume Forecast by Application
13.4.1. Adults
13.4.2. Children
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Ear Drops Market Size and Volume Forecast by Type
13.7.1. Ciprodex Ear Drop
13.7.2. Gentisone HC Ear Drop
13.7.3. Ciproxin HC Ear Drop
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Ear Drops Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Ear Drops Market: Market Share Analysis
14.2. Ear Drops Distributors and Customers
14.3. Ear Drops Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Daiichi Sankyo
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Neilmed
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. TRP
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Prestige Brands, Inc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Walgreen
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Hyland's
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Similasan
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Clarion Brands Inc
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Debrox
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Auro-Dri Ear
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Equate
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
